Summary. The effect of plasmid pUKll23, which confers low level resistance to trimethoprim when tested on solid minimal medium, but almost no resistance when tested on IsoSensitest agar, was investigated in liquid media. The growth of Escherichia coli J62-2, harbouring pUKll23, was unaffected in liquid minimal medium containing trimethoprim 10 mg/L. However, in IsoSensitest broth, exposure to this drug concentration resulted in bacteriostasis. After an initial delay, resistance to trimethoprim was induced in IsoSensitest broth containing trimethoprim 10 mg/L, by the imposition of thymine starvation. This response was immediately reversible when trimethoprim was removed, confirming that resistance resulted from induction rather than selection of resistant mutants.
Introduction
Trimethoprim selectively inhibits bacterial dihydrofolate reductase (EC 1.5.1.3), which catalyses the reduction of dihydrofolate to the active co-factor tetrahydrofolate.' Bacterial resistance to trimethoprim most commonly results from the plasmid-or transposon-directed synthesis of an additional trimethoprim-insensitive dihydrofolate reductase which allows the inhibited host target enzyme to be bypassed. 2 The MIC of trimethoprim for bacteria harbouring trimethoprim-resistance plasmids (R-plasmids) is usually > 1000mg/L,3,4 although there are reports of Rplasmids conferring only moderate levels of resistance to trimethoprim (MIC 64-250 mg/L). [5] [6] [7] [8] The action of trimethoprim on the bacterial cell can be either bacteriostatic or bactericidal, depending on the composition of the medium.' Sensitive strains of Escherichia coli die rapidly in the presence of trimethoprim if L-methionine, glycine and a purine derivative are present in the medium. This has been compared to " thymineless death" since the effect is reversed by the presence of thymine derivatives.' The effect of L-methionine, glycine and purine derivatives is to preserve the integrity of the tetrahydrofolic acid pool during trimethoprim treatment. This allows protein synthesis to occur, which is essential for the death of the organism. ' In 1985 we reported a new type of trimethoprim Rplasmid which confers on E. coli hosts only a moderate level of trimethoprim resistance, the extent of which depends on the test agar.l0 MICs of trimethoprim for bacteria harbouring these plasmids ranged from 160 mg/L, when measured in minimal medium, to only 5mg/L when measured in various complex media." This results from hyperproduction of a novel dihydrofolate reductase, type IV, encoded by the plasmid and triggered by the metabolic conditions imposed on the cell by trimethoprim, which emulates thymine starvation, rather than by trimethoprim itself.ll We now report the in-vitro effect of trimethoprim on E. coli K-12 carrying the plasmid pUKll23 and examine whether hyperproduction of the enzyme results from induction of the resistance mechanism or selection of resistant mutants.
Materials and methods
Bacterial strains and plasmids E. coli K-12 strain J62-2 (pro his trp),12 which is susceptible to trimethoprim, was used as the standard host strain. The R-plasmid pUKll23 was identified in a strain of E. coli isolated in South India, and confers resistance to trimethoprim, sulphamethoxazole and streptomycin. l3
Media
The minimal medium used was that described by Davis and Mingioli14 and was prepared as described by Smith. culturing 0.5 ml of stationary phase cultures into 9.5 ml of pre-warmed IsoSensitest broth, or appropriately supplemented minimal medium, and incubating for 2 h at 37 "C in an orbital incubator. These cultures (0.1 ml) were then diluted into 9.9 ml of suitably supplemented pre-warmed media, with and without trimethoprim 10 mg/L, and incubated statically at 37 "C. Samples were taken every hour for 6 h and the viable count was estimated by plating serial dilutions (in minimal medium) on MacConkey Agar (CM7b, Oxoid). The plates were incubated at 37 "C for 18 h and the resultant colonies were counted.
To investigate the effect of pre-exposure to trimethoprim, E. coli 562-2 (pUK1123) was grown overnight in IsoSensitest broth containing trimethoprim 10mg/L and then diluted into pre-warmed IsoSensitest broth with or without trimethoprim. After incubation at 37 "C for 2 h, the cultures were again diluted into IsoSensitest broth either with or without trimethoprim ( fig. 1) . The viable count was monitored for 6 h as before. As a control, identical procedures were applied to E. coli 562-2 lacking the plasmid except that this strain was grown initially overnight in the absence of trimethoprim.
Results and discussion
Bacteria were challenged with trimethoprim 10 mg/L, since this concentration caused hyperproduction of the type IV dihydrofolate reductase but had only a small effect on cell viability.
Growth response in minimal and complex media
A very gradual reduction in viable count was observed after subculture of E. coli 562-2 into minimal medium containing trimethoprim 10 mg/L. When plasmid pUK1123 was present in the strain, the bacteria multiplied at a rate similar to that observed in medium without trimethoprim ( fig. 2) . In IsoSensitest broth, the control strain died rapidly in the presence of trimethoprim, but the strain harbouring the plasmid was merely inhibited by trimethoprim 10 mg/L ( fig. 3) . Thus, in complex medium trimethoprim had a bacteriostatic effect on cells harbouring pUK 1 123 ; whereas in minimal medium the plasmid offered full protection. 
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Investigation of the bacteriostatic nature of trimethoprim
Since the response of plasmid-free bacteria to trimethoprim depends on the presence of L-methionine, glycine and purine derivatives in the m e d i~m ,~ the growth of bacteria harbouring pUK1123 was examined in minimal medium to which these defined supplements had been added. In this medium trimethoprim caused bacteriostasis of E. coli 562-2 (pUKll23) similar to that observed in IsoSensitest broth, but with very slight growth of the bacteria (fig.  4) . Thus, other supplement(s) may be required to cause complete bacteriostasis.
Mode of trimethoprim resistance mediated by plasmid p UKll23
On prolonged incubation, without shaking, at 37 "C for a further 16 h E. coli J62-2 (pUK1123) multiplied in IsoSensitest broth containing trimethoprim to give a viable count of c. 10scfu/ml, whereas the viable count of the strains lacking the plasmid, grown under similar conditions, was only lo4 cfu/ml.
There are two possible explanations for this observation: either a genetic mutant, resistant to trimethoprim 10 mg/L, had evolved and was selected in the presence of trimethoprim, or phenotypic adaptation to the presence of the drug had occurred. In order to test which of these two possibilities was correct, the effect of removing the trimethoprim pressure for 2 h was investigated ( fig. 1) .
Bacteria harbouring plasmid pUKll23 and grown continuously in the presence of trimethoprim in complex medium grew at a similar rate in the presence and absence of trimethoprim after subculture into fresh broth ( fig. 5 ). In contrast, bacteria which had been subcultured into medium lacking trimethoprim for only 2 h reverted to their original phenotype, showing a bacteriostatic response to subsequent challenge with trimethoprim ( fig. 6 ). E. coli 562-2, lacking the plasmid, was killed by trimethoprim, regardless of whether the strain had ( fig. 5) or had not (fig. 6 ) been continuously exposed to the drug. These results suggest that resistance is induced by trimethoprim in the plasmid-containing strain.
The trimethoprim R-plasmid pUK 1 123 confers only a moderate level of resistance on its host. This depends on the composition of the medium, with almost negligible resistance being conferred on solid complex media.lo The present results show that the presence of plasmid pUK1123 in E. coli permits the bacteria to 
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Time (h) grow apparently unaffected in liquid minimal medium containing trimethoprim 10 mg/L. This suggests that conventional methods of sensitivity testing on agar plates would not reflect the true response to trimethoprim of bacteria harbouring plasmid pUKll23. In IsoSensitest broth, the initial effect of the plasmid was to allow its bacterial host merely to survive, without multiplication, in the presence of trimethoprim. Experiments in supplemented minimal medium revealed that this response resulted from the presence of L-methionine, broth. Trime t hoprim pUKll23 results plasmid-encoded glycine and adenine in IsoSensitest resistance mediated by plasmid from the production of an inducible dihydrofolate reductase which is only slightly resistant to trimethoprim (Ki = 63 n~) . l~ The basal level of production of this enzyme is about four times that of the sensitive host chromosomal enzyme and a 12-fold increase occurs in the presence of trimethoprim 10 mg/L. 17 The presence of this resistant enzyme explains the ability of organisms harbouring plasmid pUKll23 to remain viable in complex media containing trimethoprim, and induced synthesis of the enzyme in the presence of trimethoprim offers an explanation for the subsequent growth observed following trimethoprim challenge.
The type IV enzyme has been detected only in South India but appears to be still common-there 5 years after the original isolations? It is tempting to speculate that such an unusual resistance mechanism may be the result of conditions prevalent in the Third World, namely frequent intermittent low dosing with trimethoprim in combination with frequent infections. It is not difficult to imagine how the type IV enzyme could be successful in these conditions, especially if located on the same plasmid as other resistance genes. Bacteria containing transferable low-level resistance to trimethoprim have also been isolated from healthy subjects in Nigeria, although it is not known if this results from a type IV-like enzyme. 
